| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.17 | 0.6 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.6 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |